These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36497271)

  • 21. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
    Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus.
    Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Svoboda M; Sachlova M; Slaby O
    Diagn Pathol; 2015 Apr; 10():42. PubMed ID: 25928282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis.
    Trevellin E; Pirozzolo G; Fassan M; Vettor R
    J Cancer; 2020; 11(14):4240-4249. PubMed ID: 32368307
    [No Abstract]   [Full Text] [Related]  

  • 24. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectins in the tumor endothelium: opportunities for combined cancer therapy.
    Thijssen VL; Poirier F; Baum LG; Griffioen AW
    Blood; 2007 Oct; 110(8):2819-27. PubMed ID: 17591944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
    Saussez S; Camby I; Toubeau G; Kiss R
    Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
    Xue J; Jia E; Ren N; Xin H
    Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PROGNOSTIC FACTORS AND SURVIVAL ANALYSIS IN ESOPHAGEAL CARCINOMA.
    Tustumi F; Kimura CM; Takeda FR; Uema RH; Salum RA; Ribeiro-Junior U; Cecconello I
    Arq Bras Cir Dig; 2016; 29(3):138-141. PubMed ID: 27759773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectokines: The Promiscuous Relationship between Galectins and Cytokines.
    Sanjurjo L; Broekhuizen EC; Koenen RR; Thijssen VLJL
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
    Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
    Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma.
    Wu CF; Lee CT; Kuo YH; Chen TH; Chang CY; Chang IW; Wang WL
    Tumour Biol; 2017 Sep; 39(9):1010428317725922. PubMed ID: 28945168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.
    Lau LS; Mohammed NBB; Dimitroff CJ
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 90K (Mac-2 BP) and galectins in tumor progression and metastasis.
    Grassadonia A; Tinari N; Iurisci I; Piccolo E; Cumashi A; Innominato P; D'Egidio M; Natoli C; Piantelli M; Iacobelli S
    Glycoconj J; 2002; 19(7-9):551-6. PubMed ID: 14758079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectins in Endothelial Cell Biology and Angiogenesis: The Basics.
    Thijssen VL
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
    Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
    Front Oncol; 2016; 6():109. PubMed ID: 27242953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of galectins in colorectal cancer progression.
    Barrow H; Rhodes JM; Yu LG
    Int J Cancer; 2011 Jul; 129(1):1-8. PubMed ID: 21520033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
    Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
    Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.